Clinical Trial Update: Study Comparing Daratumumab, Lenalidomide, and Dexamethasone With Lenalidomide and Dexamethasone in Participants With Previously Untreated Multiple Myeloma [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Daratumumab, Lenalidomide, and Dexamethasone (DRd) with Lenalidomide and Dexamethasone (Rd) in previously untreated multiple myeloma has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DARZALEX (daratumumab)
• Decadron (Dexamethasone)
• Revlimid (lenalidomide)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Multiple Myeloma | Phase 3 | Status: COMPLETED | Results posted: 2020-01-09